{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:32:55Z","timestamp":1791318775594,"version":"4.3.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"University of Palermo (Italy) for funding"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.ijpharm.2016.06.042","type":"journal-article","created":{"date-parts":[[2016,6,27]],"date-time":"2016-06-27T04:01:09Z","timestamp":1467000069000},"page":"263-270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Realization of polyaspartamide-based nanoparticles and in vivo lung biodistribution evaluation of a loaded glucocorticoid after aerosolization in mice"],"prefix":"10.1016","volume":"510","author":[{"given":"E.F.","family":"Craparo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Di Gioia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Trapani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Cellamare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Belgiovine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Mandracchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Giammona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Cavallaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Conese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2016.06.042_bib0005","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1517\/17425247.2015.993968","article-title":"Pulmonary delivery of anti-inflammatory agents","volume":"12","author":"Ali","year":"2015","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2016.06.042_bib0010","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.2042-7158.1984.tb04868.x","article-title":"Biotransformation of the topical glucocorticoids budesonide and beclomethasone 17 alpha,21-dipropionate in human liver and lung homogenate","volume":"36","author":"Andersson","year":"1984","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2016.06.042_bib0015","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1056\/NEJM199503303321307","article-title":"Inhaled glucocorticoids for asthma","volume":"332","author":"Barnes","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijpharm.2016.06.042_bib0020","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1080\/10611860400013477","article-title":"Glycosylated macromolecular conjugates of antiviral drugs with a polyaspartamide","volume":"12","author":"Cavallaro","year":"2004","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ijpharm.2016.06.042_bib0025","doi-asserted-by":"crossref","first-page":"54S","DOI":"10.1378\/chest.130.1_suppl.54S","article-title":"Developing the ideal inhaled corticosteroid","volume":"130","author":"Cerasoli","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.ijpharm.2016.06.042_bib0030","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1166\/jnn.2015.9178","article-title":"Beclomethasone dipropionate-loaded polymeric nanocapsules: development, in vitro cytotoxicity, and in vivo evaluation of acute lung injury","volume":"15","author":"Chassot","year":"2015","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.ijpharm.2016.06.042_bib0035","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1021\/bm060570c","article-title":"PEGylated Nanoparticles based on a polyaspartamide preparation, physico-chemical characterization, and intracellular uptake","volume":"7","author":"Craparo","year":"2006","journal-title":"Biomacromole"},{"key":"10.1016\/j.ijpharm.2016.06.042_bib0040","doi-asserted-by":"crossref","first-page":"485603","DOI":"10.1088\/0957-4484\/19\/48\/485603","article-title":"Biocompatible polymeric micelles with polysorbate 80 for use in brain targeting","volume":"19","author":"Craparo","year":"2008","journal-title":"Nanotechnology"},{"key":"10.1016\/j.ijpharm.2016.06.042_bib0045","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1007\/s11051-009-9842-4","article-title":"Nanoparticles based on novel amphiphilic polyaspartamide copolymers","volume":"12","author":"Craparo","year":"2010","journal-title":"J. Nanopart. Res."},{"key":"10.1016\/j.ijpharm.2016.06.042_bib0050","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijpharm.2010.12.024","article-title":"Phospholipid-polyaspartamide micelles for pulmonary delivery of corticosteroids","volume":"406","author":"Craparo","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.06.042_bib0055","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1166\/jbn.2013.1608","article-title":"Novel composed galactosylated nanodevices containing a ribavirin prodrug as hepatic cell-targeted carriers for HCV treatment","volume":"9","author":"Craparo","year":"2013","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.ijpharm.2016.06.042_bib0060","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1021\/bm4002409","article-title":"Galactosylated micelles for a ribavirin prodrug targeting to hepatocytes","volume":"14","author":"Craparo","year":"2013","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ijpharm.2016.06.042_bib0065","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.polymdegradstab.2015.05.003","article-title":"Evaluation of biodegradability on polyaspartamide-Polylactic acid based nanoparticles by chemical hydrolysis studies","volume":"119","author":"Craparo","year":"2015","journal-title":"Polym. Degrad. Stab."},{"key":"10.1016\/j.ijpharm.2016.06.042_bib0070","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1002\/marc.201500154","article-title":"Polyaspartamide-Polylactide graft copolymers with tunable properties for the realization of fluorescent nanoparticles for imaging","volume":"36","author":"Craparo","year":"2015","journal-title":"Macromol. Rapid Commun."},{"key":"10.1016\/j.ijpharm.2016.06.042_bib0075","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1021\/acs.biomac.5b01480","article-title":"Pegylated polyaspartamide-Polylactide-Based nanoparticles penetrating cystic fibrosis artificial mucus","volume":"17","author":"Craparo","year":"2016","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ijpharm.2016.06.042_bib0080","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.addr.2014.05.008","article-title":"Improving the efficacy of inhaled drugs in cystic fibrosis: challenges and emerging drug delivery strategies","volume":"75","author":"d'Angelo","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2016.06.042_bib0085","first-page":"87","article-title":"A comparison of beclomethasone dipropionate and budesonide in the treatment of asthma","volume":"47","author":"Davies","year":"1993","journal-title":"Br. J. Clin."},{"key":"10.1016\/j.ijpharm.2016.06.042_bib0090","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/1520-6017(200009)89:9<1143::AID-JPS6>3.0.CO;2-C","article-title":"Comparative kinetics of metabolism of beclomethasone propionate esters in human lung homogenates and plasma","volume":"89","author":"Foe","year":"2000","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.06.042_bib0095","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.rmed.2005.11.029","article-title":"Higher patient perceived side effects related to higher daily doses of inhaled corticosteroids in the community: a cross-sectional analysis","volume":"100","author":"Foster","year":"2006","journal-title":"Respir. Med."},{"key":"10.1016\/j.ijpharm.2016.06.042_bib0100","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1465-9921-6-21","article-title":"Monitoring the initial pulmonary absorption of two different beclomethasone dipropionate aerosols employing a human lung reperfusion model","volume":"6","author":"Freiwald","year":"2005","journal-title":"Respir. Res."},{"key":"10.1016\/j.ijpharm.2016.06.042_bib0105","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1002\/pola.1987.080251016","article-title":"\u03b1,\u03b2-poly(N-2-hydroxyethyl)-d,l-aspartamide with derivatives of carboxylic acids","volume":"25","author":"Giammona","year":"1987","journal-title":"J. Polym. Sci. A: Polym. Chem."},{"key":"10.1016\/j.ijpharm.2016.06.042_bib0110","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1053\/rmed.2002.1457","article-title":"Fundamentals of pulmonary drug delivery","volume":"97","author":"Groneberg","year":"2003","journal-title":"Respir. Med."},{"key":"10.1016\/j.ijpharm.2016.06.042_bib0115","first-page":"422P","article-title":"Absorption and metabolism of steroids administered intratracheally to rat isolated lungs [proceedings]","volume":"57","author":"Hartiala","year":"1976","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ijpharm.2016.06.042_bib0120","first-page":"294","article-title":"Absorption and metabolism of intratracheally instilled cortisol and beclomethasone dipropionate in the isolated perfused rat lungs","volume":"57","author":"Hartiala","year":"1979","journal-title":"Med. Biol."},{"key":"10.1016\/j.ijpharm.2016.06.042_bib0125","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/j.1552-4604.1997.tb04262.x","article-title":"Pharmacokinetic\/pharmacodynamic aspects of aerosol therapy using glucocorticoids as a model","volume":"37","author":"Hochhaus","year":"1997","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ijpharm.2016.06.042_bib0130","series-title":"The Metabolic Potential of the Lungs. Presystemic Drug Elimination","first-page":"117","author":"Hook","year":"1982"},{"key":"10.1016\/j.ijpharm.2016.06.042_bib0135","unstructured":"ICH Harmonised Tripartite Guideline, Stability Testing of New Drug Substances and Products Q1A(R2). 2003. http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Quality\/Q1A_R2\/Step4\/Q1A_R2__Guideline.pdf."},{"key":"10.1016\/j.ijpharm.2016.06.042_bib0140","doi-asserted-by":"crossref","first-page":"e77730","DOI":"10.1371\/journal.pone.0077730","article-title":"Self-assembling nanoparticles containing dexamethasone as a novel therapy in allergic airways inflammation","volume":"8","author":"Keynon","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpharm.2016.06.042_bib0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.colsurfb.2009.09.001","article-title":"Biodegradable polymeric nanoparticles based drug delivery systems","volume":"75","author":"Kumari","year":"2010","journal-title":"Colloids Surf. B: Biointer."},{"key":"10.1016\/j.ijpharm.2016.06.042_bib0150","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ijpharm.2012.04.052","article-title":"PHEA-graft-polybutylmethacrylate copolymer microparticles for delivery of hydrophobic drugs","volume":"433","author":"Licciardi","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.06.042_bib0155","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.addr.2014.05.017","article-title":"Delivery strategies for sustained drug delivery release in the lungs","volume":"75","author":"Loira-Pastoriza","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2016.06.042_bib0160","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1034\/j.1399-3003.2000.15d22.x","article-title":"Tumour necrosis factor-alpha production in human alveolar macrophages: modulation by inhaled corticosteroid","volume":"15","author":"Marshall","year":"2000","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ijpharm.2016.06.042_bib0165","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/cpt1974153267","article-title":"Absorption and metabolism of orally administered beclomethsone dipropionate","volume":"15","author":"Martin","year":"1974","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ijpharm.2016.06.042_bib0170","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cellimm.2009.07.004","article-title":"Effect of betamethasone phosphate loaded polymeric nanoparticles on a murine asthma model","volume":"260","author":"Matsuo","year":"2009","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.ijpharm.2016.06.042_bib0175","doi-asserted-by":"crossref","first-page":"4871","DOI":"10.1016\/S0032-3861(03)00486-5","article-title":"Molecular characterization of \u03b1,\u03b2-poly(N-2-hydroxyethyl)-dl-aspartamide derivatives as potential self-assembling copolymers forming polymeric micelles","volume":"44","author":"Mendichi","year":"2003","journal-title":"Polymer"},{"key":"10.1016\/j.ijpharm.2016.06.042_bib0180","first-page":"623","article-title":"Reversible fatty acid conjugation of budesonide: novel mechanism for prolonged retention of topically applied steroid in airway tissue","volume":"26","author":"Miller-Larsson","year":"1998","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ijpharm.2016.06.042_bib0185","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.nano.2015.01.007","article-title":"Inhalable nanoparticulate powders for respiratory delivery","volume":"11","author":"Muralidharan","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ijpharm.2016.06.042_bib0190","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1465-9921-8-65","article-title":"In vitro metabolism of beclomethasone dipropionate, budesonide, ciclesonide, and fluticasone propionate in human lung precision-cut tissue slices","volume":"8","author":"Nave","year":"2007","journal-title":"Respir. Res."},{"key":"10.1016\/j.ijpharm.2016.06.042_bib0195","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0091-6749(98)70322-7","article-title":"Measuring efficacy and safety of different inhaled corticosteroid preparations","volume":"102","author":"O\u2019Byrne","year":"1998","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ijpharm.2016.06.042_bib0200","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1124\/jpet.112.202556","article-title":"Metabolism of beclomethasone dipropionate by cytochrome P450 3A enzymes","volume":"345","author":"Roberts","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ijpharm.2016.06.042_bib0205","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.2147\/IJN.S25363","article-title":"Rehydrated sterically stabilized phospholipid nanomicelles of budesonide for nebulization: physicochemical characterization and in vitro, in vivo evaluations","volume":"6","author":"Sahib","year":"2011","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpharm.2016.06.042_bib0210","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/ddr.21000","article-title":"Incorporation of beclomethasone dipropionate into polyethylene glycol-Diacyl lipid micelles as a pulmonary delivery system","volume":"73","author":"Sahib","year":"2012","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ijpharm.2016.06.042_bib0215","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1365-2125.2012.04210.x","article-title":"Urinary pharmacokinetic methodology to determine the relative lung bioavailability of inhaled beclometasone dipropionate","volume":"74","author":"Said","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ijpharm.2016.06.042_bib0220","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0168-3659(02)00034-2","article-title":"Mucoadhesive beclomethasone microspheres for powder inhalation: their pharmacokinetics and pharmacodynamics evaluation","volume":"80","author":"Sakagami","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2016.06.042_bib0225","first-page":"1","article-title":"Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases","volume":"3","author":"Smola","year":"2008","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpharm.2016.06.042_bib0230","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/bdd.2510110503","article-title":"Activation of beclomethasone dipropionate by hydrolysis to beclomethasone-17-monopropionate","volume":"11","author":"Wurthwein","year":"1990","journal-title":"Biopharm. Drug Dispos."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037851731630518X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037851731630518X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T23:51:19Z","timestamp":1536623479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037851731630518X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S037851731630518X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2016.06.042","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Realization of polyaspartamide-based nanoparticles and in vivo lung biodistribution evaluation of a loaded glucocorticoid after aerosolization in mice","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2016.06.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}